- 1、本文档共61页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
《周围神经病》ppt课件
Clinical features of AIDP(2) 3-5% have complete ophthalmoplegia 15% have autonomic manifestation labile blood pressure, cardiac arrhythmias, bladder dysfunction, constipation, abdominal distension, bloating Neurologic examination Quadriplegia: Muscle weakness and atrophy Muscle stretch reflexes are absent or depressed Cranial nerve paralysis Sensory loss in a stocking-glove distribution Pain in low back, buttocks, thigh Exacerbated by straight leg raising Autonomic dysfunction CSF 90% of cases, protein is elevated by the nadir of illness without leukocytosis. 5% of cases, pleocytosis 10 (10-20) cells/mm3. OB (oligoclonal bands) IgG/24h increasing MBP increasing Special Antibodies : GM1 Electro-diagnostic studies AIDP: Demyelination Axonal AMAN/AMSAN: Axonal Demyelination Sural nerve biopsy demyelinating and remyelinating axonal degeneration Infiltration of inflammatory cells : lymphocytes,macrophages deposition of Ig and complements Course Most patients of AIDP become maximally weak within 11-12 days of onset. AMSN and AMAN usually reach nadir within 6 days. Most patients progress steadily, occasionally, stuttering or stepwise course. The average time to onset of recovery is 4 weeks. Diagnosis Clinical feature: acute progressive quadriplegia CSF: dissociation of protein/leukocytes F-wave, NCV, EMG, MEP Sural nerve biopsy Special antibodies in serum and CSF Differential diagnosis Periodic paralysis Poliomyelitis Myelitis Toxic neuropathy Lyme’s disease Myositis Treatment of GBS (1) Support care Prevent complications Rehabilitation Psychology support immunotherapy Treatment of GBS (2) Immunotherapy Plasma exchange (PE) Iv Ig PE + IV Ig? Corticosteroid? IV Ig+ Corticosteroid? Prognosis 80% recovery within 6 months 15% have severe residual disability Mortality rate is 3%-5%. Cause of death: ARDS with or without sepsis, dysautonomia. Chronic inflammatory demyelinating pol
您可能关注的文档
- 《口腔卫生我知道》PPT课件.ppt
- 《口腔沟通比喻》PPT课件.ppt
- 《口腔护理操作规范》PPT课件.ppt
- 《口腔护理基础》ppt课件.ppt
- 《口腔相关护理知识》PPT课件.pptx
- 《口腔相关护理可发》PPT课件.pptx
- 《口腔院内感染》ppt课件.pptx
- 《口腔科品管圈》ppt课件.ppt
- 《口腔解剖生理》PPT课件.ppt
- 《古代婚姻礼仪》PPT课件.ppt
- 《JJF 2132-2024荧光紫外灯人工气候老化试验装置校准规范:辐射照度参数》.pdf
- JJF 2120-2024轮速传感器校准规范.pdf
- 计量规程规范 JJF 2120-2024轮速传感器校准规范.pdf
- 《JJF 2129-2024钙钛矿太阳电池校准规范:光电性能参数》.pdf
- JJF 2129-2024钙钛矿太阳电池校准规范:光电性能参数.pdf
- 《JJF 2120-2024轮速传感器校准规范》.pdf
- JJF 2117-2024沥青混合料理论最大相对密度仪校准规范.pdf
- JJF 2116-2024特定蛋白分析仪校准规范.pdf
- 《JJF 2116-2024特定蛋白分析仪校准规范》.pdf
- 计量规程规范 JJF 2117-2024沥青混合料理论最大相对密度仪校准规范.pdf
文档评论(0)